Piper Sandler maintains a neutral recommendation for
Becton Dickinson (BDX). BDX surges past Q4 earnings and revenue estimates demonstrating
strong earnings, despite a complex forecast. BDX's projected high single-digit profit growth and planned share buybacks have spurred optimism. Veritas Asset Management LLP has added 852,854 BDX shares to its portfolio. BDX completes enrollment for vital research study, demonstrating its commitment to innovation. However, Becton Dickinson's stock experiences a decline after a slight EPS beat in Q4 2025. The company also faces uncertainties with a CFO transition plan on the horizon.
Despite the recent 22% drop, investors have seen an opportunity in BDX’s share price based on stronger earnings and confident 2026 targets. BDX also recently announced a dividend increase. Valuations are under reassessment after a quiet trading period. BDX anticipates significant growth to its share price, having been undervalued by 27%.
Negative sentiment prevails due to mixed fundamentals and the recent CFO exit. The company's shares fell due to a decline in organic revenue growth. However, BDX’s new AI-enabled solutions aim to drive connectivity across healthcare settings showing promise for forward-thinking strategies and future growth. The consensus remains mixed, yet Q4 earnings rose above expectations, suggesting promising results for upcoming earnings reports.
Becton Dickinson and BDX News Analytics from Mon, 17 Mar 2025 07:00:00 GMT to Sat, 08 Nov 2025 00:16:54 GMT -
Rating 6
- Innovation 8
- Information 7
- Rumor 5
